Gabriel N Hortobagyi

37PUBLICATIONS
215CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsMolecular medicineCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (37)

|Apr 11, 2025
Novel Postneoadjuvant Prognostic Breast Cancer Staging System.

David J Winchester, Lavisha Singh, Stephen B Edge

|Feb 28, 2025
Health-Related Quality of Life in Patients with HR+/HER2- Early Breast Cancer Treated with Ribociclib Plus a Nonsteroidal Aromatase Inhibitor: Results from the NATALEE Trial.

Peter A Fasching, Dennis Slamon, Zbigniew Nowecki

|Dec 10, 2024
Race and clinical outcomes in hormone receptor-positive, HER2-negative, node-positive breast cancer in the randomized RxPONDER trial.

Yara Abdou, William E Barlow, Julie R Gralow

|Dec 02, 2024
Development and Validation of the RSClinN+ Tool to Predict Prognosis and Chemotherapy Benefit for Hormone Receptor-Positive, Node-Positive Breast Cancer.

Lajos Pusztai, Jess R Hoag, Kathy S Albain

|Oct 02, 2024
Targeting the Epidermal Growth Factor Receptor Pathway in Chemotherapy-Resistant Triple-Negative Breast Cancer: A Phase II Study.

Clinton Yam, Miral Patel, Holly A Hill

|Jun 04, 2024
Phase III Randomized, Placebo-Controlled Trial of Endocrine Therapy ± 1 Year of Everolimus in Patients With High-Risk, Hormone Receptor-Positive, Early-Stage Breast Cancer.

Mariana Chavez-MacGregor, Jieling Miao, Lajos Pusztai

Pageof 7

Frequent Collaborators

10 joint publications

Lajos Pusztai

9 joint publications

Priyanka Sharma

9 joint publications

William E Barlow

8 joint publications

Daniel F Hayes